Evidence map›Paper›PMID 24083452›Full record

ReviewCritical reviews in biotechnology2014

Clinical translation of stem cells: insight for cartilage therapies.

Jennifer K Lee, Donald J Responte, Derek D Cissell, Jerry C Hu, Jan A Nolta, Kyriacos A Athanasiou

Open access · greenAbstract readReview
In one paragraph

Review in Critical reviews in biotechnology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Stem Cells in Spinal Fusion.Global spine journal · 2017
    Article
  10. Visible light crosslinking of methacrylated hyaluronan hydrogels for injectable tissue repair.Journal of biomedical materials research. Part B, Applied biomaterials · 2016
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jennifer K LeeDepartment of Biomedical Engineering, University of California , Davis, CA , USA .
Donald J Responte
Derek D Cissell
Jerry C Hu
Jan A Nolta
Kyriacos A Athanasiou
University of California, Davis · USUniversity of California Davis Medical Center · US

Funding

TMJ Disc RegenerationR01DE015038 · NIDCR · UNIVERSITY OF CALIFORNIA-IRVINE · PI ATHANASIOU, KYRIACOS A · 2004 to 2022
$6.1M
Comparative Medical Science Training ProgramT32OD011147 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI JEROEN SAEIJ, Sara Michelle Thomasy · 2012 to 2026
$5.5M
Direct cell to cell transfer of microRNA for tissue repairR01GM099688 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI NOLTA, JAN A. · 2011 to 2015
$2.7M
Training Program in Biomolecular TechnologyT32GM008799 · NIGMS · UNIVERSITY OF CALIFORNIA DAVIS · PI LEACH, J. KENT · 2002 to 2016
$2.4M
Toward Tissue Engineering of the Knee MeniscusR01AR047839 · NIAMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI ATHANASIOU, KYRIACOS A · 2003 to 2010
$2.1M
Regenerating the fibrocartilage spectrum of the TMJ: from disc to condyleR01DE019666 · NIDCR · UNIVERSITY OF CALIFORNIA AT DAVIS · PI ATHANASIOU, KYRIACOS A · 2010 to 2013
$1.4M
Self-Assembling Process in Tissue Engineering of Articular CartilageR01AR053286 · NIAMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI ATHANASIOU, KYRIACOS A · 2007 to 2011
$1.3M
NIAMS NIH HHS R01 AR047839NIAMS NIH HHS R01 AR053286NIDCR NIH HHS R01 DE015038NIDCR NIH HHS R01 DE019666NIGMS NIH HHS R01 GM099688NIGMS NIH HHS T32 GM008799NIH HHS T32 OD011147
6 · The paper itself

Abstract

The limited regenerative capacity of articular cartilage and deficiencies of current treatments have motivated the investigation of new repair technologies. In vitro cartilage generation using primary cell sources is limited by cell availability and expansion potential. Pluripotent stem cells possess the capacity for chondrocytic differentiation and extended expansion, providing a potential future solution to cell-based cartilage regeneration. However, despite successes in producing cartilage using adult and embryonic stem cells, the translation of these technologies to the clinic has been severely limited. This review discusses recent advances in stem cell-based cartilage tissue engineering and the major current limitations to clinical translation of these products. Concerns regarding appropriate animal models and studies, stem cell manufacturing, and relevant regulatory processes and guidelines will be addressed. Understanding the significant hurdles limiting the clinical use of stem cell-based cartilage may guide future developments in the fields of tissue engineering and regenerative medicine.

Indexed as

CartilageRegenerative MedicineStem CellsTissue EngineeringAnimalsHumansMice

Identifiers

PMID24083452
PMCPMC4314285
OpenAlexW2059241173

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.